Literature DB >> 17183270

Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue.

J P J Saeij1, S Coller, J P Boyle, M E Jerome, M W White, J C Boothroyd.   

Abstract

Toxoplasma gondii, an obligate intracellular parasite of the phylum Apicomplexa, can cause severe disease in humans with an immature or suppressed immune system. The outcome of Toxoplasma infection is highly dependent on the strain type, as are many of its in vitro growth properties. Here we use genetic crosses between type II and III lines to show that strain-specific differences in the modulation of host cell transcription are mediated by a putative protein kinase, ROP16. Upon invasion by the parasite, this polymorphic protein is released from the apical organelles known as rhoptries and injected into the host cell, where it ultimately affects the activation of signal transducer and activator of transcription (STAT) signalling pathways and consequent downstream effects on a key host cytokine, interleukin (IL)-12. Our findings provide a new mechanism for how an intracellular eukaryotic pathogen can interact with its host and reveal important differences in how different Toxoplasma lineages have evolved to exploit this interaction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17183270      PMCID: PMC2637441          DOI: 10.1038/nature05395

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  24 in total

1.  Significance analysis of microarrays applied to the ionizing radiation response.

Authors:  V G Tusher; R Tibshirani; G Chu
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

Review 2.  The Stat family in cytokine signaling.

Authors:  J N Ihle
Journal:  Curr Opin Cell Biol       Date:  2001-04       Impact factor: 8.382

3.  Toxoplasma evacuoles: a two-step process of secretion and fusion forms the parasitophorous vacuole.

Authors:  S Håkansson; A J Charron; L D Sibley
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

4.  Severe acquired toxoplasmosis in immunocompetent adult patients in French Guiana.

Authors:  B Carme; F Bissuel; D Ajzenberg; R Bouyne; C Aznar; M Demar; S Bichat; D Louvel; A M Bourbigot; C Peneau; P Neron; M L Dardé
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

5.  R/qtl: QTL mapping in experimental crosses.

Authors:  Karl W Broman; Hao Wu; Saunak Sen; Gary A Churchill
Journal:  Bioinformatics       Date:  2003-05-01       Impact factor: 6.937

Review 6.  Structural biology of bacterial pathogenesis.

Authors:  Han Remaut; Gabriel Waksman
Journal:  Curr Opin Struct Biol       Date:  2004-04       Impact factor: 6.809

7.  Unusual abundance of atypical strains associated with human ocular toxoplasmosis.

Authors:  M E Grigg; J Ganatra; J C Boothroyd; T P Margolis
Journal:  J Infect Dis       Date:  2001-07-24       Impact factor: 5.226

8.  Genotypic characterization of Toxoplasma gondii strains associated with human toxoplasmosis in Spain: direct analysis from clinical samples.

Authors:  I Fuentes; J M Rubio; C Ramírez; J Alvar
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

9.  Production of IL-12 by macrophages infected with Toxoplasma gondii depends on the parasite genotype.

Authors:  Paul M Robben; Dana G Mordue; Steven M Truscott; Kiyoshi Takeda; Shizuo Akira; L David Sibley
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

10.  v-Abl signaling disrupts SOCS-1 function in transformed pre-B cells.

Authors:  André Limnander; Nika N Danial; Paul B Rothman
Journal:  Mol Cell       Date:  2004-08-13       Impact factor: 17.970

View more
  285 in total

1.  The state of research for AIDS-associated opportunistic infections and the importance of sustaining smaller research communities.

Authors:  Anthony P Sinai; Edna S Kaneshiro; Honorine Ward; Louis M Weiss; Melanie T Cushion
Journal:  Eukaryot Cell       Date:  2011-12-09

2.  Toxoplasma gondii triggers release of human and mouse neutrophil extracellular traps.

Authors:  Delbert S Abi Abdallah; Changyou Lin; Carissa J Ball; Michael R King; Gerald E Duhamel; Eric Y Denkers
Journal:  Infect Immun       Date:  2011-11-21       Impact factor: 3.441

Review 3.  An inside job: hacking into Janus kinase/signal transducer and activator of transcription signaling cascades by the intracellular protozoan Toxoplasma gondii.

Authors:  Eric Y Denkers; David J Bzik; Barbara A Fox; Barbara A Butcher
Journal:  Infect Immun       Date:  2011-11-21       Impact factor: 3.441

4.  Toxoplasma gondii cyclophilin 18 regulates the proliferation and migration of murine macrophages and spleen cells.

Authors:  Hany M Ibrahim; Xuenan Xuan; Yoshifumi Nishikawa
Journal:  Clin Vaccine Immunol       Date:  2010-07-21

5.  Toxoplasma gondii targets a protein phosphatase 2C to the nuclei of infected host cells.

Authors:  Luke A Gilbert; Sandeep Ravindran; Jay M Turetzky; John C Boothroyd; Peter J Bradley
Journal:  Eukaryot Cell       Date:  2006-11-03

6.  miR-146a and miR-155 delineate a MicroRNA fingerprint associated with Toxoplasma persistence in the host brain.

Authors:  Dominique Cannella; Marie-Pierre Brenier-Pinchart; Laurence Braun; Jason M van Rooyen; Alexandre Bougdour; Olivier Bastien; Michael S Behnke; Rose-Laurence Curt; Aurélie Curt; Jeroen P J Saeij; L David Sibley; Hervé Pelloux; Mohamed-Ali Hakimi
Journal:  Cell Rep       Date:  2014-02-27       Impact factor: 9.423

Review 7.  Innate resistance against Toxoplasma gondii: an evolutionary tale of mice, cats, and men.

Authors:  Ricardo T Gazzinelli; Rondon Mendonça-Neto; Jingtao Lilue; Jonathan Howard; Alan Sher
Journal:  Cell Host Microbe       Date:  2014-02-12       Impact factor: 21.023

8.  Th1 and Th2 immune response to P30 and ROP18 peptides in human toxoplasmosis.

Authors:  Elizabeth Torres-Morales; Laura Taborda; Nestor Cardona; Alejandra De-la-Torre; Juan Carlos Sepulveda-Arias; Manuel Alfonso Patarroyo; Jorge Enrique Gomez-Marin
Journal:  Med Microbiol Immunol       Date:  2014-05-11       Impact factor: 3.402

9.  Expression of the essential Kinase PfCDPK1 from Plasmodium falciparum in Toxoplasma gondii facilitates the discovery of novel antimalarial drugs.

Authors:  Rajshekhar Y Gaji; Lisa Checkley; Michael L Reese; Michael T Ferdig; Gustavo Arrizabalaga
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

10.  The arginine-rich N-terminal domain of ROP18 is necessary for vacuole targeting and virulence of Toxoplasma gondii.

Authors:  Sarah J Fentress; Tobias Steinfeldt; Jonathan C Howard; L David Sibley
Journal:  Cell Microbiol       Date:  2012-09-20       Impact factor: 3.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.